These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6773178)

  • 1. In vivo release of anti-Xa clotting activity by a heparin analogue.
    Thomas DP; Barrowcliffe TW; Merton RE; Stocks J; Dawes J; Pepper DS
    Thromb Res; 1980 Mar; 17(6):831-40. PubMed ID: 6773178
    [No Abstract]   [Full Text] [Related]  

  • 2. Nature of the anti-Xa activity induced by a heparin analogue (SSHA) in vivo.
    Schmitz-Huebner U; Lobreyer EM; van de Loo J
    Thromb Res; 1982 Sep; 27(6):757-62. PubMed ID: 6817453
    [No Abstract]   [Full Text] [Related]  

  • 3. In vivo studies on the inhibition of coagulation by fractionated heparin and by a heparin analogue. II. Effects of a heparin analogue.
    Schmitz-Huebner U; Asbeck F; van de Loo J
    Thromb Haemost; 1981 Oct; 46(3):617-20. PubMed ID: 6797091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anticoagulant properties of mast cell product, chondroitin sulphate E.
    Scully MF; Ellis V; Seno N; Kakkar VV
    Biochem Biophys Res Commun; 1986 May; 137(1):15-22. PubMed ID: 3087353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of unfractionated heparin, low-molecular-weight heparin, and heparinoid on thromboelastographic assay of blood coagulation.
    Zmuda K; Neofotistos D; Ts'ao CH
    Am J Clin Pathol; 2000 May; 113(5):725-31. PubMed ID: 10800406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of danaparoid sodium, dalteparin sodium and heparin determined by inhibitory effect on the activated coagulation factor X activity after single intravenous administration in rabbits.
    Ishida M; Nakada Y; Horiuchi M; Sakamoto F
    Arzneimittelforschung; 1998 Aug; 48(8):818-21. PubMed ID: 9748709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Törngren S; Norén I; Forsskåhl B; Sipilä H
    Thromb Res; 1983 Jun; 30(5):527-34. PubMed ID: 6412390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulant activity of dermatan polysulfates.
    Akiyama F; Seno N; Yoshida K
    Tohoku J Exp Med; 1982 Apr; 136(4):359-65. PubMed ID: 6808700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anticoagulant effect of heparan sulfate and dermatan sulfate.
    Teien AN; Abildgaard U; Höök M
    Thromb Res; 1976 Jun; 8(6):859-67. PubMed ID: 134464
    [No Abstract]   [Full Text] [Related]  

  • 10. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
    Gatt A; van Veen JJ; Woolley AM; Kitchen S; Cooper P; Makris M
    Thromb Haemost; 2008 Aug; 100(2):350-5. PubMed ID: 18690358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of protamine and heparin after termination of cardiopulmonary bypass by thrombelastometry (ROTEM): results of a pilot study.
    Mittermayr M; Velik-Salchner C; Stalzer B; Margreiter J; Klingler A; Streif W; Fries D; Innerhofer P
    Anesth Analg; 2009 Mar; 108(3):743-50. PubMed ID: 19224778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic heparin analogue and prothrombin time.
    Kakkar VV; Djazaeri B; Scully M; Weerasinghe K
    Lancet; 1981 May; 1(8230):1167. PubMed ID: 6112524
    [No Abstract]   [Full Text] [Related]  

  • 13. [Changes in the adhesiveness of thrombocytes under the effect of anticoagulants].
    Merkulov MF; Lakin KM; Fel'dbaum VA; Efimov VS
    Farmakol Toksikol; 1968; 31(6):706-9. PubMed ID: 5713582
    [No Abstract]   [Full Text] [Related]  

  • 14. Interactions of oversulfated chondroitin sulfate (OSCS) from different sources with unfractionated heparin.
    Gray A; Litinas E; Jeske W; Fareed J; Hoppensteadt D
    Clin Appl Thromb Hemost; 2012; 18(2):166-73. PubMed ID: 22311630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiocoagulant activity of chondroitin sulfate A, B and C.--co-operative action with heparin cofactor (author's transl)].
    Shiba T; Takeuchi S; Awazu S; Igarashi M; Asada T
    Nihon Ketsueki Gakkai Zasshi; 1978 Jun; 41(3):560-3. PubMed ID: 696196
    [No Abstract]   [Full Text] [Related]  

  • 16. Conventional heparin and semisynthetic heparin analogue (SSHA) alteration of blood coagulation after embolic occlusion of human renal circulation.
    Törngren S; Blombäck M; Almgård LE; Norming U; Nyman CR
    Thromb Res; 1990 Jul; 59(2):237-46. PubMed ID: 2122536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of oversulfated and fucosylated chondroitin sulfates on coagulation. Challenges for the study of anticoagulant polysaccharides.
    Fonseca RJ; Oliveira SN; Pomin VH; Mecawi AS; Araujo IG; Mourão PA
    Thromb Haemost; 2010 May; 103(5):994-1004. PubMed ID: 20352164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular profiling of heparinase-I resistant glycosaminoglycans in contaminated heparins. Comparative studies with uncontaminated heparin and porcine oversulfated chondroitin sulfate.
    Clark M; Hoppensteadt D; Walenga J; Myers L; Cunanan J; Jeske W; Adiguzel C; Iqbal O; Fareed J
    Int Angiol; 2008 Oct; 27(5):370-6. PubMed ID: 18974698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contaminated heparin-affected patient plasmas are associated with activated contact systems.
    Yi Qian ; Jing Pan ; Xiaodong Zhou ; Weiser P; Hong Lu ; Beck AM; Shih FF; Lijuan Zhang
    Clin Appl Thromb Hemost; 2010 Jun; 16(3):261-5. PubMed ID: 20547554
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of post-heparin plasma lipases on anti-Xa clotting activity.
    Williams SP; Barrowcliffe TW
    Thromb Res; 1985 Feb; 37(3):371-7. PubMed ID: 3992526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.